Skip to content

DR. SASKIA FOLENS

Active
Private limited companyfounded 2019active for 6 yearsAlbert Termotelaan 14, 8810 Lichtervelde, BelgiumKBO/BCE: BE 0737.623.434
Summary

DR. SASKIA FOLENS has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €209,369 and a net result of €34,342. Equity has been growing by about 19% per year since 2020. Its solvency ranks better than 32% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 13-11-2019 Normal situation
Activity
General medical practice NACE 86210and 1 other
Establishment unit
2.295.964.858 8810 Lichtervelde, since 13-11-2019
Financial year end
31 December
Peppol
Reachable since 17-02-2026

Board and ownership

Board
  • FOLENS SASKIADirector

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€83,749
▲ 16.7%
Turnover
≈ €190,000
estimated
Profit
€34,342
▲ 57.9%
Equity
€209,369
▲ 19.1%
Total assets
€531,782
▼ 3.5%
  • 2025 accounts filed 29 days after the deadline
Score breakdownraises riskLast filed accounts filed 29 days late; 1 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Size: total assets €531,782Figures for financial year 2025 (filed on 29-08-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 37% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 64+7
equity 39.4% of total assets
Liquidity 57-18
short-term debt 25.7% · cash 13.6%
Profitability 77+4
return on assets 6.5%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026highest value 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €19,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.36 (2.48 in 2024), above the usual 1.5. Short-term debt is 25.7% and cash 13.6% of total assets. However, 60.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 32% of them on solvency, 33% on liquidity, 21% on profitability and 63% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Last filed accounts filed 29 days late; 1 of the last 3 accounts late
NBB · filings
lowers risk · Size: total assets €531,782
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 29-08-2026)
NBB · annual accounts
raises risk · 2025 accounts filed 29 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-08-2026, 29 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 6 filings
Deviation from the deadline
2025
29 days late
2024
30 days late
2023
31 days late
2022
31 days late
2021
30 days late
2020
30 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 30 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 7th largest company by total assets in Lichtervelde, Health and social work…in the Checked rankings No. 7 View
  • Positive: 6 profitable years in a rowprofit 2025: €34,342 6 years View

Recent changes

  1. · Gazette deed Incorporation
All 10 events

Comparable companies

These companies have the same main activity as DR. SASKIA FOLENS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €426,000 and €512,000, founded between 2018 and 2020.

CompanyTotal assetsGross margin
DR. SASKIA FOLENS Lichtervelde€531,782€83,749
DR. GERTJAN DE FLOU Beernem€511,766€85,230
Dr. Elise Landuyt Tielt€511,636€84,906
Dokter Maarten Avet, huisarts Gent€508,469€89,008
GOIGNE STEPHANIE Lichtervelde€501,720€100,521
Dr. Katrien Pallemaerts Brugge€426,375€86,395
Dr. Ellen Dupont Oostkamp€471,100€99,389
Full comparison

Key facts about DR. SASKIA FOLENS

What is the company number of DR. SASKIA FOLENS?
The company number of DR. SASKIA FOLENS is 0737.623.434. The VAT number is the same number with BE in front: BE 0737.623.434.
Where is DR. SASKIA FOLENS based?
The registered office is at Albert Termotelaan 14, 8810 Lichtervelde.Company details
What does DR. SASKIA FOLENS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. SASKIA FOLENS?
The legal form of DR. SASKIA FOLENS is Private limited company (BV).
When was DR. SASKIA FOLENS founded?
DR. SASKIA FOLENS was founded on 13-11-2019.
Is DR. SASKIA FOLENS still active?
Yes, DR. SASKIA FOLENS is an active enterprise in the KBO register.
What is the turnover of DR. SASKIA FOLENS?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €83,749 and 32 comparable companies (NACE 862). It probably lies between €150,000 and €240,000.Financials
Is DR. SASKIA FOLENS profitable?
In financial year 2025, DR. SASKIA FOLENS made a profit of €34,342.
Where can I find the annual accounts of DR. SASKIA FOLENS?
DR. SASKIA FOLENS filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. SASKIA FOLENS due?
DR. SASKIA FOLENS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.